By BY KATIE THOMAS AND NOAH WEILAND from NYT Health
https://ift.tt/3fkqXKY
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
No comments:
Post a Comment